定义翻修全髋关节置换术的术前贫血阈值
该研究回顾性纳入2019至2024年单中心连续翻修全髋关节置换术患者,模拟术前血细胞比容39%至33%的阈值进行手术批准或拒绝。结果显示设置术前贫血阈值可能降低再入院、输血、并发症和非家庭出院的可能性。
要点
- 模拟最严格39%血细胞比容阈值下,1118例中626例(56%)被拒绝手术。
- 被拒绝手术者相比被批准者再入院、输血、非家庭出院和并发症均更高。
- 术前血红蛋白高于12.7 g/dL可降低再入院可能性(AUC 0.548,PPV 0.889)。
核心结论
- 设置翻修全髋关节置换术的术前贫血阈值可能降低再入院、输血、并发症和非家庭出院的可能性。
研究设计与样本
- 回顾性审查2019至2024年单中心连续翻修全髋关节置换术患者。
- 排除原发性全髋关节置换术、无术前血细胞比容和1年随访不完整的患者。
- 使用术前血细胞比容39%至33%的模拟截断值,高于阈值者批准手术,低于阈值者拒绝手术。
主要发现
- 最严格39%血细胞比容阈值下,1118例中626例(56%)被拒绝手术,被拒绝者再入院16.9% vs 被批准者13.2%,术中输血45.7% vs 11.6%,术后输血37.2% vs 14%,非家庭出院66% vs 35.8%,并发症38.2% vs 24.6%。
- 最宽松33%血细胞比容阈值下,1118例中271例(24.2%)被拒绝手术,被拒绝者再入院17% vs 被批准者14.8%,术中输血56.5% vs 22.4%,术后输血44.3% vs 21.5%,非家庭出院81.9% vs 43.3%,并发症42.4% vs 28.9%。
- 术前血红蛋白高于12.7 g/dL降低再入院可能性(AUC 0.548,PPV 0.889)。
- 术前血红蛋白高于11.8 g/dL降低术中输血可能性(AUC 0.770,PPV 0.847)。
- 术前血红蛋白高于12.0 g/dL降低术后输血可能性(AUC 0.713,PPV 0.853)。
关键数值与推荐
- 模拟术前血细胞比容截断值39%至33%用于批准或拒绝手术。
- 术前血红蛋白高于12.7 g/dL对应再入院AUC 0.548、PPV 0.889;高于11.8 g/dL对应术中输血AUC 0.770、PPV 0.847;高于12.0 g/dL对应术后输血AUC 0.713、PPV 0.853;高于11.8 g/dL对应非家庭出院AUC 0.730、PPV 0.632;高于12.0 g/dL对应术后并发症AUC 0.620、PPV 0.767。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In an era of value-based medical management, anemia optimization before revision total hip arthroplasty (THA) could improve outcomes. Simulation models in orthopedic literature help define the likelihood of successful surgery based on varying thresholds of preoperative parameters. We evaluated outcomes for revision THA if patients were either approved/denied surgery based on incremental preoperative anemia thresholds. METHODS: We retrospectively reviewed consecutive revision THA patients from 2019 to 2024 at a single institution. Exclusion criteria were primary THA, no preoperative hematocrit, and incomplete 1-year follow-up. Simulated preoperative hematocrit cutoffs of 39 through 33% were used. Preoperative hematocrit above each threshold was "approved" for surgery, while below each threshold was "denied" surgery. Intraoperative transfusions, postoperative transfusions, discharge dispositions, 90-day readmissions, and complications were evaluated. Area under the curve (AUC) determined anemia thresholds needed for an event not to occur. RESULTS: If the strictest 39% hematocrit threshold were used, 626 of 1,118 (56%) patients would be denied surgery, with denied patients having higher readmissions (16.9 versus 13.2%), intraoperative transfusions (45.7 versus 11.6%), postoperative transfusions (37.2 versus 14%), nonhome discharge (66 versus 35.8%), and complications (38.2 versus 24.6%) compared to approved counterparts. If the most lenient hematocrit 33% threshold were used, 271 of 1,118 (24.2%) patients would be denied surgery, with even higher readmissions (17 versus 14.8%), intraoperative transfusions (56.5 versus 22.4%), postoperative transfusions (44.3 versus 21.5%), nonhome discharge (81.9 versus 43.3%), and complications (42.4 versus 28.9%) compared to approved counterparts. A preoperative hemoglobin above 12.7 g/dL reduced the likelihood of readmission (AUC 0.548, Positive Predictive Value [PPV] 0.889), above 11.8 g/dL reduced intraoperative transfusion (AUC 0.770, PPV 0.847), above 12.0 g/dL reduced postoperative transfusion (AUC 0.713, PPV 0.853), above 11.8 g/dL reduced nonhome discharge (AUC 0.730, PPV 0.632), and above 12.0 g/dL reduced postoperative complications (AUC 0.620, PPV 0.767). CONCLUSIONS: Setting preoperative anemia thresholds for revision THA eligibility may reduce the likelihood of readmissions, transfusions, complications, and nonhome discharges.
引用
- Sutton R, Leipman JH, Linton A, et al. Defining Preoperative Anemia Thresholds for Revision Total Hip Arthroplasty. J Arthroplasty. 2025. PMID: 41138992. doi:10.1016/j.arth.2025.10.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。